Showing results (391-400 of 686) with videos related to

Sort By:
Pageof 69
Arthritis Care & Research|November 12, 2015
Correlation Between Changes in Global Knee Structures Assessed by Magnetic Resonance Imaging and Radiographic Osteoarthritis Changes Over Ten Years in a Midlife CohortHussain Ijaz Khan, Louisa Chou, Dawn Aitken, et al.
The Journal of Rheumatology|September 3, 2017
Associations Between Knee Effusion-synovitis and Joint Structural Changes in Patients with Knee OsteoarthritisXia Wang, Xingzhong Jin, Leigh Blizzard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2017
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical TrialNicola Dalbeth, Graeme Jones, Robert Terkeltaub, et al.
BMC Musculoskeletal Disorders|February 3, 2016
Does cartilage volume measurement or radiographic osteoarthritis at baseline independently predict ten-year cartilage volume loss?Andrew McBride, Hussain Ijaz Khan, Dawn Aitken, et al.
Seminars in Arthritis and Rheumatism|November 9, 2019
Association of glucose homeostasis and metabolic syndrome with knee cartilage defects and cartilage volume in young adultsTao Meng, Benny Antony, Alison Venn, et al.
Annals of the Rheumatic Diseases|August 16, 2015
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugsChristina Charles-Schoeman, Gerd Burmester, Peter Nash, et al.
Rheumatology and Therapy|December 17, 2024
Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational StudyPeter C Taylor, Walid Fakhouri, Samuel Ogwu, et al.
Journal of Comparative Effectiveness Research|September 20, 2018
Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysisIain B McInnes, Peter Nash, Christopher Ritchlin, et al.
Rheumatology and Therapy|April 2, 2018
Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect ComparisonPeter Nash, Iain B McInnes, Philip J Mease, et al.
Rheumatology and Therapy|June 23, 2019
Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 StudyAlan J Kivitz, Peter Nash, Hasan Tahir, et al.
Pageof 69